Protein Sciences Overview
- Year Founded
-
1983
- Status
-
Acquired/Merged
- Employees
-
88
- Latest Deal Type
-
M&A
- Financing Rounds
-
9
Protein Sciences General Information
Description
Developer and producer of vaccines and proteins intended to save lives and improve health by effectively responding to the changing world. The company's bio-pharmaceuticals platform offers vaccines for influenza, SARS and other diseases and uses its platform production system to make human and veterinary prophylactic and therapeutic vaccines.
Contact Information
Website
www.proteinsciences.comCorporate Office
- 1000 Research Parkway
- Meriden, CT 06450
- United States
Corporate Office
- 1000 Research Parkway
- Meriden, CT 06450
- United States
Protein Sciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Protein Sciences Comparisons
Industry
Financing
Details
Protein Sciences Competitors (63)
One of Protein Sciences’s 63 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genentech | Formerly VC-backed | South San Francisco, CA | ||||
Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany | ||||
Centrose | Venture Capital-Backed | Middleton, WI | ||||
Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
Aceragen | Corporation | Durham, NC |
Protein Sciences Patents
Protein Sciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2014111650-A | Method for preparing influenza hemagglutinin polyvalent vaccine | Inactive | 28-Feb-2014 | ||
CA-2899731-A1 | Improved stability and potency of hemagglutinin | Inactive | 15-Mar-2013 | ||
AU-2014234034-A1 | Improved stability and potency of hemagglutinin | Inactive | 15-Mar-2013 | ||
EP-2968522-A1 | Improved stability and potency of hemagglutinin | Inactive | 15-Mar-2013 | ||
EP-2968522-A4 | Improved stability and potency of hemagglutinin | Inactive | 15-Mar-2013 | A61K39/145 |
Protein Sciences Signals
Protein Sciences Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Protein Sciences FAQs
-
When was Protein Sciences founded?
Protein Sciences was founded in 1983.
-
Where is Protein Sciences headquartered?
Protein Sciences is headquartered in Meriden, CT.
-
What is the size of Protein Sciences?
Protein Sciences has 88 total employees.
-
What industry is Protein Sciences in?
Protein Sciences’s primary industry is Pharmaceuticals.
-
Is Protein Sciences a private or public company?
Protein Sciences is a Private company.
-
What is the current valuation of Protein Sciences?
The current valuation of Protein Sciences is
. -
What is Protein Sciences’s current revenue?
The current revenue for Protein Sciences is
. -
How much funding has Protein Sciences raised over time?
Protein Sciences has raised $27.1M.
-
Who are Protein Sciences’s investors?
Diamyd Medical, Eurand, Nihon Nosan Kogyo, Pacific Rim Ventures, and The Ropart Asset Management Funds have invested in Protein Sciences.
-
Who are Protein Sciences’s competitors?
Genentech, Boehringer Ingelheim, Centrose, Cristal Therapeutics, and Aceragen are some of the 63 competitors of Protein Sciences.
-
When was Protein Sciences acquired?
Protein Sciences was acquired on 25-Aug-2017.
-
Who acquired Protein Sciences?
Protein Sciences was acquired by Sanofi.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »